APA

Poleshchuk N. N., Rubanik L. V., Kapitulets N. N., Kvacheva Z. B., Kostiuk S. A., Chernosheĭ D. A., Kapitulets S. P. & Titov L. P. (20080820). [Biological and immunogenic characteristics of Chlamydia trachomatis strain MT-2A (serovar D) and its use for development of experimental inactivated vaccine]. : Zhurnal mikrobiologii, epidemiologii i immunobiologii.

Chicago

Poleshchuk N N, Rubanik L V, Kapitulets N N, Kvacheva Z B, Kostiuk S A, Chernosheĭ D A, Kapitulets S P and Titov L P. 20080820. [Biological and immunogenic characteristics of Chlamydia trachomatis strain MT-2A (serovar D) and its use for development of experimental inactivated vaccine]. : Zhurnal mikrobiologii, epidemiologii i immunobiologii.

Harvard

Poleshchuk N. N., Rubanik L. V., Kapitulets N. N., Kvacheva Z. B., Kostiuk S. A., Chernosheĭ D. A., Kapitulets S. P. and Titov L. P. (20080820). [Biological and immunogenic characteristics of Chlamydia trachomatis strain MT-2A (serovar D) and its use for development of experimental inactivated vaccine]. : Zhurnal mikrobiologii, epidemiologii i immunobiologii.

MLA

Poleshchuk N N, Rubanik L V, Kapitulets N N, Kvacheva Z B, Kostiuk S A, Chernosheĭ D A, Kapitulets S P and Titov L P. [Biological and immunogenic characteristics of Chlamydia trachomatis strain MT-2A (serovar D) and its use for development of experimental inactivated vaccine]. : Zhurnal mikrobiologii, epidemiologii i immunobiologii. 20080820.